Table 3 Logistic regression analysis of coexistence of lipid profiles and NSCLC TNM stage
From: Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study
Lipid profiles (mmol/l) | Control (n = 414) | TNM I | TNM II | TNM III-IV | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Cases (n = 202) | Crude OR (95% CI) | Adjusted OR (95% CI) | Cases (n = 85) | Crude OR (95% CI) | Adjusted OR (95% CI) | Cases (n = 137) | Crude OR | Adjusted OR | ||
HDL-C | ||||||||||
Low (< 1.0) | 74 | 65 | 1 | 1 | 37 | 1 | 1 | 68 | 1 | 1 |
Normal (≥1.0& < 1.5) | 260 | 110 | 0.486(0.326–0.725) | 0.473(0.292–0.768) | 40 | 0.308 (0.184–0.516) | 0.254(0.134–0.480) | 57 | 0.239(0.154–0.369) | 0.204(0.120–0.348) |
High (≥1.5) | 80 | 27 | 0.370 (0.213–0.644) | 0.271 (0.132–0.555) | 8 | 0.200 (0.087–0.457) | 0.144(0.052–0.398) | 12 | 0.163(0.082–0.326) | 0.108(0.046–0.256) |